-

Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board

Appointment of Dr. Navneet Boddu to Expand Patient Access to Stem Cells in FDA Compliant Manner

ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI), announced today the appointment of internationally renowned stem cell therapist Dr. Navneet Boddu to the Company’s Scientific Advisory Board. Dr. Boddu joins eminent luminaries in the regenerative medicine/immunotherapy space such as Dr. Santosh Kesari, Dr. Francesco Marincola1, Dr. Donald Banerji2, and Dr. Boris Minev3.

Dr. Boddu previously obtained for Therapeutic Solutions International Emergency IND approval to treat a patient with COVID-19 using JadiCells. Therapeutic Solutions International plans to expand ongoing patient access to JadiCells as it advances in their development.

“I have known Dr. Boddu and his pioneering work in the area of regenerative medicine for some time now and it is an honor to finally work with him in a formal manner,” said Dr. Thomas Ichim, Board Member of Therapeutic Solutions International. “Dr. Boddu represents a very rare combination of excellent scientist, doctor, and businessperson. He has pioneered numerous medical procedures and is well known and respected in the stem cell community.”

Dr. Boddu is affiliated with Scripps Memorial Medical Center, Encinitas; Tri City Medical Center; North Coast Surgery Center; and Carlsbad Surgery Center. He is board certified in Pain Medicine, Anesthesiology and Echocardiography. Dr. Boddu was chosen as Top Doctor of San Diego in 2022, 2021, and 2017.

“As an organization, we are rapidly advancing on many fronts of regenerative medicine including the treatment of aortic aneurysms (VasoSome Vascular Inc)4, chronic traumatic encephalopathy (CTE Biologics Inc)5, chronic obstructive pulmonary disease (Breath Biologics Inc)6, mental illness (Campbell Neurosciences Inc)7, and Oncology (Res Nova Bio Inc)8. Working with a regenerative medicine pioneer who has numerous experiences with the FDA will assist in accelerating progress of these programs through regulatory agencies,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “I met Dr. Boddu during the COVID19 crisis during which his leadership in bringing stem cells to patients had saved numerous lives. We are truly excited to join forces with a true “medical hero.”

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com.

1 Therapeutic Solutions International, Inc. Appoints Francesco Marincola to Scientific Advisory Board -July 23, 2018 at 09:00 am EDT | MarketScreener
2 Therapeutic Solutions International Recruits Dr. Donald Banerji to Scientific Advisory Board | BioSpace
3 Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board | BioSpace
4 Therapeutic Solutions Launches VasoSome Vascular Inc. to Commercialize Aortic Aneurysm Treatment - Endovascular Today (evtoday.com)
5 Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells (yahoo.com)
6 Spinoff Breathe Biologics to Lead TSOI's Stem Cell Therapy Research | COPD News Today
7 Therapeutic Solutions International Announces Titan of Industry Dr. Peter Farrell Joins Advisory Board of its Suicide Prevention Spin-Off Campbell Neurosciences (prnewswire.com)
8 Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses | Business Wire

Contacts

Timothy G. Dixon
ir@tsoimail.com

Industry:

Therapeutic Solutions International, Inc.

OTC Pink:TSOI
Release Versions
English

Contacts

Timothy G. Dixon
ir@tsoimail.com

More News From Therapeutic Solutions International, Inc.

Therapeutic Solutions International to Voluntarily Delist

ELK CITY, Idaho--(BUSINESS WIRE)--Timothy G Dixon, Therapeutic Solutions International CEO issued the following statement: Therapeutic Solutions International, Inc. (TSOI) announced today their intent to delist and “go dark” from the public markets. Please take Notice: on April 22, 2025, the Board of Directors, with the consent of a majority of eligible voting shareholders of the Company, approved a voluntary withdrawal of the class of securities from listing and registration on the Exchange an...

Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases

ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI) announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office regarding its patent application entitled “Stimulation of Mesenchymal Stem Cell Therapeutics Activities by Regulatory T Cells.” The issued patent claims include: “A method of inhibiting lung inflammation comprising: a) identifying a subject suffering from lung inflammation; b) administering a population of T regula...

Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board

ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company. Therapeutic Solutions International pre-spin-off company, Campbell Neurosciences, Inc., announced today appointment of seasoned public company veteran Mr. Raymond Oliver as Chairman of its Board of Directors. This move is part of a larger strategy the suicide prevention company is impl...
Back to Newsroom